Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Parkinson's Disease (2)
Nature Microbiology (2)
Nature (2)
npj Vaccines (1)
npj Digital Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Amendments and Corrections (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Diseases
Health care
Immunology
Medical research
Microbiology
Neurology
Neuroscience
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–9 of 9 results

Advanced filters: Author: Timothy Endy Clear advanced filters

A framework for risk–benefit analysis of vaccines approved through accelerated pathways

Using a statistical model that incorporates transmission intensity and stratum-specific rates of severe outcomes, either associated with disease or vaccination, a framework is proposed to compare the risks and benefits of deploying new vaccines, using early epidemiological data.

Bethan Cracknell Daniels
Timothy Endy
Henrik Salje
ResearchOpen Access15 Jan 2026
Nature Health

Volume: 1, P: 120-128
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study

Virological, clinical and immunological characterization of a dengue virus 3 human challenge model could help with identifying vaccine and drug candidates.

Adam T. Waickman
Krista Newell
Stephen J. Thomas
Research01 Apr 2024
Nature Microbiology

Volume: 9, P: 1356-1367
Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand

Derek A.T. Cummings
Rafael A. Irizarry
Donald S. Burke
Research22 Jan 2004
Nature

Volume: 427, P: 344-347
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

Analyses of antibody dynamics and subclinical infections show that across the population, variability in the infection strength of dengue viruses results in large-scale temporal changes in infection and disease risk that correlate poorly with age.

Henrik Salje
Derek A. T. Cummings
Simon Cauchemez
Research23 May 2018
Nature

Volume: 557, P: 719-723
Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort study

Herd immunity to dengue acts at the household level according to a longitudinal, multigenerational cohort study.

Marco Hamins-Puértolas
Darunee Buddhari
Kathryn B. Anderson
Research18 Dec 2023
Nature Microbiology

Volume: 9, P: 274-283
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

Kirsten I. Taylor
Florian Lipsmeier
Stefano Zanigni
ResearchOpen Access16 Jun 2025
npj Digital Medicine

Volume: 8, P: 1-12
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials

Gennaro Pagano
Dylan Trundell
Stefano Zanigni
ResearchOpen Access01 Jul 2025
npj Parkinson's Disease

Volume: 11, P: 1-8
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials

Gennaro Pagano
Dylan Trundell
Stefano Zanigni
Amendments and CorrectionsOpen Access13 Aug 2025
npj Parkinson's Disease

Volume: 11, P: 1
Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need

Neil Cherian
Alison Bettis
Timothy Endy
ReviewsOpen Access18 Aug 2023
npj Vaccines

Volume: 8, P: 1-8